Daily as of 3 Nov 16:00 ET
- Price
- above both $52.20 vs 50 $51.19 / 200 $31.73
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 20 Feb 2026 · projected 14 bars out
PLSE | Pulse BiosciencesNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$52.20
-$0.70 (-1.32%)
Pulse Biosciences (PLSE) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
The 50 SMA has sat above the 200 on the daily since Feb 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $52.24 vs 50 $28.52 / 200 $16.00
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 30 Sep 2024 · projected 26 bars out
4-hour as of 3 Nov 13:30 ET
- Price
- above both $53.60 vs 50 $50.57 / 200 $42.24
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 12 Feb 2026 · projected 12 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 20 Feb 2026 | 🟨Golden steep | daily | 14 bars out | Not tested |
| 12 Feb 2026 | 🟨Golden | 4-hour | 12 bars out | Not tested |
| 3 Dec 2025 | 💀Death moderate | daily | 30 bars out | Not tested |
| 20 Nov 2025 | 💀Death | 4-hour | 30 bars out | Not tested |
| 29 Oct 2025 | 🟨Golden moderate | daily | 22 bars out | 2 bar cross test |
About PLSE
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$22.2M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandmid